Developing therapeutics against the kinesin KIFC1 as treatments for triple negative breast cancer - Research Portal | Lancaster University

Home > Research > Activities > Developing therapeutics against the kinesin KIF...

Biomedical and Life Sciences

View graph of relations

Developing therapeutics against the kinesin KIFC1 as treatments for triple negative breast cancer

Activity: Talk or presentation types › Invited talk

Dr Andrew Fielding - Speaker

2/07/2025

Invited talk at NWCR Research Symposium

Event (Symposium)

Title	North West Cancer Research Symposium
Date	2/07/25 → 2/07/25
Location	Edge Hill University
City